Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Zydus Lifesciences BP lowering drug receives USFDA tentative nod

Ruchika Sharma4 July 2024 4:46 PM IST

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to market...

London HC decision fuels continued legal battle between Pfizer, Moderna over COVID vaccine patents

Ruchika Sharma4 July 2024 4:10 PM IST

London: Pfizer and Moderna's legal dispute over their competing COVID-19 vaccines is poised to persist following a mixed ruling from London's...

IPOs in global biopharma industry surge to USD 8.52 billion in 2024: Report

Nephro Care India IPO subscribed nearly 716 times

Ruchika Sharma4 July 2024 2:30 PM IST

New Delhi: Nephro Care India's initial public offering (IPO) was subscribed 715.85 times on Tuesday, largely driven by robust participation from...

CureVac announces resolution of patent litigation with Pfizer/BioNTech

Viatris unit Mylan, former President Rajiv Malik cleared in US Department of Justice generic drug antitrust probe

Ruchika Sharma4 July 2024 1:00 PM IST

Pittsburgh: Viatris Inc. has announced that the Antitrust Division of the U.S. Department of Justice (DOJ) has advised that it no longer...

Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mg

Sun Pharma pulled up by USFDA for manufacturing issues at Dadra facility

Ruchika Sharma4 July 2024 11:30 AM IST

Mumbai: Sun Pharma did not sufficiently clean and maintain the equipment used in drug manufacturing at its manufacturing plant in Dadra,...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning

Ruchika Sharma3 July 2024 6:45 PM IST

The U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma

Ruchika Sharma3 July 2024 2:00 PM IST

Paris: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...

Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancer

Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease

Ruchika Sharma3 July 2024 11:20 AM IST

Indianapolis: Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved Alzheimer's treatment Kisunla...

AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC

Lynparza, Imfinzi combo recommended for nod in EU by CHMP for endometrial cancer: AstraZeneca

Ruchika Sharma3 July 2024 10:00 AM IST

Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU)...

nod for Ibuprofen, Paracetamol Film-coated Tablets

Marksans Pharma arm bags UKMHRA marketing authorization for Rasagiline Relonchem, Olmesartan tablets

Ruchika Sharma2 July 2024 5:13 PM IST

Mumbai: Marksans Pharma has announced that its wholly-owned subsidiary Relonchem Limited has received Marketing Authorization from UKMHRA...

Sanofi plans up to USD 1.6 billion investment in Germany: Handelsblatt

Ruchika Sharma2 July 2024 2:50 PM IST

Frankfurt: French pharmaceutical company, Sanofi, is close to deciding on an investment ranging between 1.3 billion euros and 1.5 billion euros...

Novartis to buy Tourmaline Bio for USD 1.4 billion

KKR buys controlling stake in Baby Memorial Hospital

Ruchika Sharma2 July 2024 12:13 PM IST

Mumbai: Global investment firm, KKR, will acquire a controlling stake in Baby Memorial Hospital, a regional multi-specialty hospital chain in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok